Intro to Janus Kinase (JAK) Inhibitors for Treatment of Atop

Peter Lio, MD, and Lisa Swanson, MD, PhD, provide an overview of Janus Kinase (JAK) inhibitors, their pathophysiology, and their mechanism of action in the treatment of atopic dermatitis (AD).

Related Keywords

Alexandra Golant , Lisa Swanson , Peter Leo , Christopher Bunick , , Peter Lio , Jak Inhibitors , Janus Kinase , Atopic Dermatitis , Pathophysiology , Inflammatory Process , Jak Stat Pathway , Multicytokine Disease , Pitch ,